"We want to make sure practices have time to learn, understand, adapt, and modify, to a new Oncology Care Model," said Michael Diaz, MD, president of Community Oncology Alliance.
"We want to make sure practices have time to learn, understand, adapt, and modify, to a new Oncology Care Model," said Michael Diaz, MD, president of Community Oncology Alliance.
Transcript:
Community Oncology Alliance (COA) recommended delaying the start of Oncology Care Model's (OCM's) successor model. How will having more time in the OCM benefit practices?
Well, there are several reasons. First of all, 2021 is less than a year away, and we don't have details on this new model. In order to have practices evolve, change, and implement new processes—and I think that's one of the key things here — there are a lot of new fundamental components that are different than the Oncology Care Model. We want to make sure that practices have adequate time to learn, understand, adapt, and modify. We're wanting to extend the Oncology Care Model in essence, to actually delay the initiation of the Oncology [Care] First model. That's the most important thing.
Some people will say, "Well, why can't you just complete the Oncology Care Model, delay the Oncology Care First model 6 months to a year?" Well, all the practices already had this Infrastructure set up for this type of system process. We have care coordinators, we have layers and layers of new systems that we've developed to be able to participate in these value-based care models, these alternative payment models. Without participating in a model, you can't keep and maintain your fundamental infrastructure. The majority of the practices, we feel, would experience some financial hardships trying to maintain those components of their practice if they're not participating in them all. We just think that it would help ease a transition.
Another more significant reason has to do with the fact that the Oncology Care First model, when you start in it, right now, the way it's designed, you start off in a 2-sided risk. We would like for as many community oncology practices to be able to participate in this, and not all are participating in the 2-sided risk of the Oncology Care Model. We just think a delay would allow more time to allow more practices to evolve to be able to participate
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Demographic Disparities in Video Visit Telemetry: Understanding Telemedicine Utilization
March 7th 2025A stratified demographics analysis of video visit telemetry data reveals that age older than 65 years and African American/Black race are associated with higher video visit failure rates, whereas language, sex, and ethnicity are not.
Read More